Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication

Journal of Virology

Volumn 88, Issue 19, 2014, Pages 11215-11228

  Berri, Fatma ^a   Haffar, Ghina ^a   Leˆ, Vuong Ba ^a   Sadewasser, Anne ^b   Paki, Katharina ^b   Lina, Bruno ^a   Wolff, Thorsten ^b   Riteau, Be´atrice ^a,c  

^a UNIVERSITÉ LYON 1   (France)

^b ROBERT KOCH INSTITUTE   (Germany)

^c CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LIPOCORTIN 5; CXCL10 PROTEIN, HUMAN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; STAT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGOLD STAINING; IMMUNOSURVEILLANCE; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A; INFLUENZA VIRUS; LIPID RAFT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRION; VIRUS ENVELOPE; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; CELL MEMBRANE; CHEMISTRY; DOG; DRUG ANTAGONISM; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; INFLUENZA VIRUS A; MDCK CELL LINE; METABOLISM; MONOCYTE; PROTEIN TRANSPORT; TUMOR CELL LINE; VIROLOGY; VIRUS LOAD;

ANIMALS; ANNEXIN A5; CELL LINE, TUMOR; CHEMOKINE CXCL10; DOGS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INTERFERON-GAMMA; MADIN DARBY CANINE KIDNEY CELLS; MEMBRANE MICRODOMAINS; MICE; MONOCYTES; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; VIRAL LOAD; VIRION; VIRUS RELEASE; VIRUS REPLICATION;

EID: 84906969498     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01405-14     Document Type: Article

References (52)

1. Fukuyama S, Kawaoka Y. 2011. The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr. Opin. Immunol. 23:481-486. http://dx.doi.org/10.1016/j.coi.2011.07.016.
2. Webby RJ, Webster RG. 2003. Are we ready for pandemic influenza? Science 302:1519-1522. http://dx.doi.org/10.1126/science.1090350.
3. Stohr K. 2002. Influenza: WHO cares. Lancet Infect. Dis. 2:517. http://dx.doi.org/10.1016/S1473-3099(02)00366-3.
4. Kuiken T, Riteau B, Fouchier RA, Rimmelzwaan GF. 2012. Pathogenesis of influenza virus infections: the good, the bad, and the ugly. Curr. Opin. Virol. 2:276-286. http://dx.doi.org/10.1016/j.coviro.2012.02.013.
5. Berri F, Le VB, Jandrot-Perrus M, Lina B, Riteau B. 2014. Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits. Cell. Mol. Life Sci. 71:885-898. http://dx.doi.org/10.1007/s00018-013-1479-x.
6. Foucault ML, Moules V, Rosa-Calatrava M, Riteau B. 2011. Role for proteases and HLA-G in the pathogenicity of influenza A viruses. J. Clin. Virol. 51:155-159. http://dx.doi.org/10.1016/j.jcv.2011.04.013.
7. Kochs G, Garcia-Sastre A, Martinez-Sobrido L. 2007. Multiple antiinterferon actions of the influenza A virus NS1 protein. J. Virol. 81:7011-7021.http://dx.doi.org/10.1128/JVI.02581-06.
8. LeBouder F, Khoufache K, Menier C, Mandouri Y, Keffous M, Lejal N, Krawice-Radanne I, Carosella ED, Rouas-Freiss N, Riteau B. 2009. Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection. Hum. Immunol. 70:1016-1019. http://dx.doi.org/10.1016/j.humimm.2009.07.026.
9. Garcia-Sastre A. 2011. Induction and evasion of type I interferon responses by influenza viruses. Virus Res. 162:12-18. http://dx.doi.org/10 .1016/j.virusres.2011.10.017.
10. Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED, Rouas-Freiss N. 1999. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 11: 1351-1356. http://dx.doi.org/10.1093/intimm/11.8.1351.
11. Nayak DP, Balogun RA, Yamada H, Zhou ZH, Barman S. 2009. Influenza virus morphogenesis and budding. Virus Res. 143:147-161. http://dx.doi.org/10.1016/j.virusres.2009.05.010.
12. Nayak DP, Hui EK, Barman S. 2004. Assembly and budding of influenza virus. Virus Res. 106:147-165. http://dx.doi.org/10.1016/j.virusres.2004 .08.012.
13. Shaw ML, Stone KL, Colangelo CM, Gulcicek EE, Palese P. 2008. Cellular proteins in influenza virus particles. PLoS Pathog. 4:e1000085. http://dx.doi.org/10.1371/journal.ppat.1000085.
14. LeBouder F, Morello E, Rimmelzwaan GF, Bosse F, Pechoux C, Delmas B, Riteau B. 2008. Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J. Virol. 82:6820-6828. http://dx.doi.org/10.1128/JVI.00246-08.
15. LeBouder F, Lina B, Rimmelzwaan GF, Riteau B. 2010. Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase. J. Gen. Virol. 91:2753-2761. http://dx.doi.org/10.1099/vir.0.023804-0.
16. Leon C, Nandan D, Lopez M, Moeenrezakhanlou A, Reiner NE. 2006. Annexin V associates with the IFN-gamma receptor and regulates IFNgamma signaling. J. Immunol. 176:5934-5942. http://dx.doi.org/10.4049 /jimmunol.176.10.5934.
17. Yan X, Doffek K, Yin C, Krein M, Phillips M, Sugg SL, Johnson B, Shilyansky J. 2012. Annexin V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo. Cancer Immunol. Immunother. 61: 1917-1927. http://dx.doi.org/10.1007/s00262-012-1250-4.
18. Riteau B, Barber DF, Long EO. 2003. Vav1 phosphorylation is induced by β2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J. Exp. Med. 198:469-474. http://dx.doi.org/10.1084/jem.20021995.
19. Riteau B, de Vaureix C, Lefevre F. 2006. Trypsin increases pseudorabies virus production through activation of the ERK signalling pathway. J. Gen. Virol. 87:1109-1112. http://dx.doi.org/10.1099/vir.0.81609-0.
20. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. 2000. Gene ontology: tool for the unification of biology. Nat. Genet. 25:25-29.
21. Riteau B, Moreau P, Menier C, Khalil-Daher I, Khosrotehrani K, Bras-Goncalves R, Paul P, Dausset J, Rouas-Freiss N, Carosella ED.Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line. Transplant Proc. 33:2360-2364. http://dx.doi.org/10.1016/S0041-1345(01)02021-8.
22. Zilberman S, Schenowitz C, Agaugue S, Benoit F, Riteau B, Rouzier R, Carosella ED, Rouas-Freiss N, Menier C. 2012. HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment. Eur. J. Immunol. 42:1599-1608. http://dx.doi.org/10.1002/eji.201141761.
23. Berri F, Rimmelzwaan GF, Hanss M, Albina E, Foucault-Grunenwald ML, Le VB, Vogelzang-van Trierum SE, Gil P, Camerer E, Martinez D, Lina B, Lijnen R, Carmeliet P, Riteau B. 2013. Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. PLoS Pathog. 9:e1003229. http://dx.doi.org/10.1371/journal.ppat.1003229.
24. Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B. 2013. PAR1 contributes to influenza A virus pathogenicity in mice. J. Clin. Invest. 123:206-214. http://dx.doi.org/10.1172/JCI61667.
25. Sagara J, Tsukita S, Yonemura S, Tsukita S, Kawai A. 1995. Cellular actin-binding ezrin-radixin-moesin (ERM) family proteins are incorporated into the rabies virion and closely associated with viral envelope proteins in the cell. Virology 206:485-494. http://dx.doi.org/10.1016/S0042-6822(95)80064-6.
26. Mok CK, Lee DC, Cheung CY, Peiris M, Lau AS. 2007. Differential onset of apoptosis in influenza A virus H5N1-and H1N1-infected human blood macrophages. J. Gen. Virol. 88:1275-1280. http://dx.doi.org/10.1099/vir.0.82423-0.
27. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. 2008. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4:e1000115. http://dx.doi.org/10.1371/journal.ppat.1000115.
28. Yu WC, Chan RW, Wang J, Travanty EA, Nicholls JM, Peiris JS, Mason RJ, Chan MC. 2011. Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J. Virol. 85:6844-6855. http://dx.doi.org/10.1128/JVI.02200-10.
29. Liu M, Guo S, Hibbert JM, Jain V, Singh N, Wilson NO, Stiles JK. 2011. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 22:121-130.
30. Garcia-Sastre A, Biron CA. 2006. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312:879-882. http://dx.doi.org/10.1126/science.1125676.
31. Gudleski-O'Regan N, Greco TM, Cristea IM, Shenk T. 2012. Increased expression of LDL receptor-related protein 1 during human cytomegalovirus infection reduces virion cholesterol and infectivity. Cell Host Microbe 12:86-96. http://dx.doi.org/10.1016/j.chom.2012.05.012.
32. Demchenko AP. 2012. The change of cellular membranes on apoptosis: fluorescence detection. Exp. Oncol. 34:263-268.
33. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. 1998. annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31: 1-9. http://dx.doi.org/10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R.
34. Niu G, Chen X. 2010. Apoptosis imaging: beyond annexin V. J. Nucl. Med. 51:1659-1662. http://dx.doi.org/10.2967/jnumed.110.078584.
35. Boon JM, Lambert TN, Sisson AL, Davis AP, Smith BD. 2003. Facilitated phosphatidylserine (PS) flip-flop and thrombin activation using a synthetic PS scramblase. J. Am. Chem. Soc. 125:8195-8201. http://dx.doi.org/10.1021/ja029670q.
36. Leser GP, Lamb RA. 2005. Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins. Virology 342:215-227. http://dx.doi.org/10.1016/j.virol.2005.09.049.
37. Rossman JS, Lamb RA. 2011. Influenza virus assembly and budding. Virology 411:229-236. http://dx.doi.org/10.1016/j.virol.2010.12.003.
38. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L, Wang D, Camp DG, 2nd, Rodland K, Wiley S, Britt W, Shenk T, Smith RD, Nelson JA. 2004. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J. Virol. 78:10960-10966. http://dx.doi.org/10.1128/JVI.78.20.10960-10966.2004.
39. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW, Jr, Sowder RC, II, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE. 2006. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 80:9039-9052. http://dx.doi.org/10.1128/JVI.01013-06.
40. Loret S, Guay G, Lippe R. 2008. Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J. Virol. 82:8605-8618. http://dx.doi.org/10.1128/JVI.00904-08.
41. Jensen ON, Houthaeve T, Shevchenko A, Cudmore S, Ashford T, Mann M, Griffiths G, Krijnse Locker J. 1996. Identification of the major membrane and core proteins of vaccinia virus by two-dimensional electrophoresis. J. Virol. 70:7485-7497.
42. Zhang C, Xue C, Li Y, Kong Q, Ren X, Li X, Shu D, Bi Y, Cao Y. 2010. Profiling of cellular proteins in porcine reproductive and respiratory syndrome virus virions by proteomics analysis. Virol. J. 7:242. http://dx.doi.org/10.1186/1743-422X-7-242.
43. Miyakawa N, Nishikawa M, Takahashi Y, Ando M, Misaka M, Watanabe Y, Takakura Y. 2011. Prolonged circulation half-life of interferon gamma activity by gene delivery of interferon gamma-serum albumin fusion protein in mice. J. Pharm. Sci. 100:2350-2357. http://dx.doi.org.org/10.1002/jps/jps.22473.
44. Karupiah G, Chen JH, Mahalingam S, Nathan CF, MacMicking JD. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J. Exp. Med. 188:1541-1546. http://dx.doi.org/10.1084/jem.188.8.1541.
45. Wiley JA, Cerwenka A, Harkema JR, Dutton RW, Harmsen AG. 2001. Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am. J. Pathol. 158:119-130. http://dx.doi.org/10.1016/S0002-9440(10)63950-8.
46. Khoufache K, LeBouder F, Morello E, Laurent F, Riffault S, Andrade-Gordon P, Boullier S, Rousset P, Vergnolle N, Riteau B. 2009. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J. Immunol. 182:7795-7802. http://dx.doi.org/10.4049/jimmunol.0803743.
47. Uetani K, Hiroi M, Meguro T, Ogawa H, Kamisako T, Ohmori Y, Erzurum SC. 2008. Influenza A virus abrogates IFN-gamma response in respiratory epithelial cells by disruption of the Jak/Stat pathway. Eur. J. Immunol. 38:1559-1573. http://dx.doi.org/10.1002/eji.200737045.
48. Huang RT, Lichtenberg B, Rick O. 1996. Involvement of annexin V in the entry of influenza viruses and role of phospholipids in infection. FEBS Lett. 392:59-62. http://dx.doi.org/10.1016/0014-5793(96)00783-1.
49. Rand JH, Wu XX, Quinn AS, Taatjes DJ. 2010. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Lupus 19:460-469. http://dx.doi.org/10.1177/0961203310361485.
50. Rand JH. 2000. The pathogenic role of annexin V in the antiphospholipid syndrome. Curr. Rheumatol. Rep. 2:246-251. http://dx.doi.org/10.1007/s11926-000-0086-7.
51. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. 2001. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br. J. Haematol. 115:451-459. http://dx.doi.org/10.1046/j.1365-2141.2001.03101.x.
52. Aerts LHM, Rhe´aume C, Lavigne S, Couture C, Kim W, Susan-Resiga D, Prat A, Seidah NG, Vergnolle N, Riteau B, Boivin G. 2013. Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model. PLoS One 28:e72529. http://dx.doi.org/10.1371/journal.pone.0072529.